Protocol-Driven Perioperative Management of Ischemic Cardiomyopathy in a Community Hospital Setting

Katherine Slusarz1,2, Brock Daughtry3, Jeremy London2

  • 1Department of Cardiothoracic Surgery, Brigham and Women's Hospital, Boston, Massachusetts.

Insights

A defined protocol for ischemic cardiomyopathy (ICM) patients undergoing coronary artery bypass grafting (CABG) in a community hospital setting reduced morbidity and mortality compared to predictions. This practical approach improves outcomes for high-risk patients.

Area of Science:

  • Cardiology
  • Cardiac Surgery

Background:

  • Ischemic cardiomyopathy (ICM) poses challenges for coronary artery bypass grafting (CABG).
  • Community hospitals face resource limitations in managing complex cardiac cases.

Purpose of the Study:

  • To evaluate a defined protocol for selecting, classifying, and treating ICM patients undergoing CABG in a nonacademic setting.
  • To assess the protocol's impact on morbidity and mortality in a resource-limited environment.

Main Methods:

  • A treatment algorithm was applied to 25 ICM patients (ejection fraction ≤0.44) requiring CABG.
  • Patients were classified preoperatively for CABG with no device, balloon pump, or direct centrifugal pump support.
  • Data collected from December 2021 to December 2023.

Main Results:

  • The protocol resulted in a 4% mortality rate versus a predicted 8.455% risk.
  • 30-day morbidity and mortality were 24%, lower than the predicted 27.7%.
  • Subgroup analysis showed better-than-expected outcomes across different risk categories.

Conclusions:

  • A defined protocol effectively manages high-risk ICM patients undergoing CABG in community hospitals.
  • The protocol demonstrated reduced morbidity and mortality compared to predictions.
  • This approach offers a practical solution for resource-limited settings.
Abstract

Related Concept Videos

Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
257
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
197
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
313
Cardiomyopathy VI: Nursing Management01:29

Cardiomyopathy VI: Nursing Management

Assessment: Nursing management of patients with cardiomyopathy begins with a thorough assessment of the patient's history, including a family history of cardiomyopathy or sudden cardiac death, personal history of heart disease, hypertension, diabetes, and any alcohol consumption or drug use.During the physical examination, assess vital signs, look for signs of heart failure (such as edema, jugular venous distention, and cyanosis), auscultate for abnormal heart sounds (like murmurs and gallops),...
296
Cardiopulmonary Resuscitation IV: Pharmacological Management01:25

Cardiopulmonary Resuscitation IV: Pharmacological Management

Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
580
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
362